Lincoln Educational Services (NASDAQ:LINC – Get Free Report)‘s stock had its “outperform” rating reissued by equities research analysts at Barrington Research in a report released on Friday, Benzinga reports. They currently have a $16.00 price target on the stock. Barrington Research’s target price suggests a potential upside of 28.31% from the company’s previous close. A […]

Henry Schein (NASDAQ:HSIC – Get Free Report)‘s stock had its “outperform” rating reissued by research analysts at Barrington Research in a research note issued to investors on Friday, Benzinga reports. They presently have a $82.00 price target on the stock. Barrington Research’s target price indicates a potential upside of 15.25% from the company’s previous close. […]

Oppenheimer reissued their outperform rating on shares of Ascendis Pharma A/S (NASDAQ:ASND – Free Report) in a research note published on Tuesday morning, Benzinga reports. They currently have a $190.00 price objective on the biotechnology company’s stock, up from their prior price objective of $180.00. ASND has been the subject of several other reports. The […]